Science Explorer Back to mapMap
Discussion
Researcher · Forma Therapeutics (United States) · United States

Bingsong Han

Bingsong Han publishes mostly in Molecular Biology, Clinical Psychology and Oncology, on topics such as Biochemical and Molecular Research, Sirtuins and Resveratrol in Medicine and Protein Degradation and Inhibitors.

OpenAlex
World rank
#1,534,319
of 7,710,434 ranked researchers
Rank in United States
#479,653
of 1,627,098
Works
18
Citations
714
Citations per work
39.7
h-index
12
i10-index 12Top 65% in Molecular Biology
Bingsong Han

What does Bingsong Han research?

Bingsong Han's work is mostly in Medicine (32%), Biochemistry, Genetics and Molecular Biology (30%), Psychology (13%).

Health Sciences: 6 works · 32.1% of their workMedicine: 6 works · 32.1% of their workOncology: 2 works · 13.2% of their workGeriatrics and Gerontology: 2 works · 9.4% of their workPublic Health, Environmental and Occupational Health: 1 works · 5.7% of their workEpidemiology: 1 works · 3.8% of their workLife Sciences: 5 works · 30.2% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 30.2% of their workMolecular Biology: 5 works · 30.2% of their workEverything else: 4 works · 24.5% of their workSocial Sciences: 2 works · 13.2% of their workPsychology: 2 works · 13.2% of their workClinical Psychology: 2 works · 13.2% of their workTHEIR WORKBingsong Han18works
Life Sciences30%Health Sciences32%Social Sciences13%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine632.1%
    1. Biochemistry, Genetics and Molecular Biology530.2%
  3. Everything else424.5%
    1. Psychology213.2%
  1. 1Molecular Biology30% of their works
  2. 2Clinical Psychology13% of their works
  3. 3Oncology13% of their works
  4. 4Geriatrics and Gerontology9% of their works
  5. 5Public Health, Environmental and Occupational Health6% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Bingsong Han's research?

The keywords of their largest research topics: Enzyme Regulation, Nucleotide Metabolism, Resveratrol, Sirtuins, BET Bromodomains, Emotion Regulation, PROTACs and Psychopathology.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Enzyme Regulation61 topic
  2. Nucleotide Metabolism61 topic
  3. Resveratrol51 topic
  4. Sirtuins51 topic
  5. BET Bromodomains31 topic
  6. Emotion Regulation31 topic
  7. PROTACs31 topic
  8. Psychopathology31 topic
  9. Autophagy21 topic
  10. BRCA Mutation21 topic
  11. CAR T Cells21 topic
  12. Chimeric Antigen Receptor21 topic
  13. Disease21 topic
  14. Drug Discovery21 topic
  15. PARP Inhibitors21 topic
  16. Peptide Synthesis21 topic

Where does Bingsong Han work?

Bingsong Han's main affiliation in the publication record is Forma Therapeutics (United States), United States.

How many publications and citations does Bingsong Han have?

OpenAlex counts 18 works and 714 citations for Bingsong Han, an h-index of 12, ranking #1,534,319 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Bingsong Han. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.